AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4362-4364

  Su, Xian Zhong ^a   Chen, Jing ^a   Mizushima, Tohru ^a,b   Kuroda, Teruo ^a   Tsuchiya, Tomofusa ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ABEM PROTEIN; ACRIFLAVINE; ANTIBIOTIC AGENT; CARRIER PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; DAUNORUBICIN; DNA FRAGMENT; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DOXORUBICIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; GENTAMICIN; HOE 33342; IMIPENEM; KANAMYCIN; MATE PROTEIN; NORFLOXACIN; OFLOXACIN; OUTER MEMBRANE PROTEIN; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RHODAMINE 6G; TETRAPHENYLPHOSPHONIUM; TRICLOSAN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; CROSS INFECTION; ENZYME SPECIFICITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; HOSPITAL INFECTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; ANTIPORTERS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CLONING, MOLECULAR; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; GENES, BACTERIAL; KINETICS; MICROBIAL SENSITIVITY TESTS; PROTON PUMPS; SEQUENCE ANALYSIS, DNA; SUBSTRATE SPECIFICITY;

EID: 25844455664     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4362-4364.2005     Document Type: Article

References (24)

1. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
2. Barbe, V., D. Vallenet, N. Fonknechten, A. Kreimeyer, S. Oztas, L. Labarre, S. Cruveiller, C. Robert, S. Duprat, P. Wincker, L. N. Ornston, J. Weissenbach, P. Marliere, G. N. Cohen, and C. Medigue. 2004. Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium. Nucleic Acids Res. 32:5766-5779.
3. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
4. Brown, M. H., I. T. Paulsen, and R. A. Skurray. 1999. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31:394-395.
5. +-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J. Bacteriol. 184:572-576.
6. Clark, R. B. 1996. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein. J. Antimicrob. Chemother. 38:245-251.
7. Fernandez-Cuenca, F., L. Martinez-Martinez, M. C. Conejo, J. A. Ayala, E. J. Perea, and A. Pascual. 2003. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565-574.
8. +-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J. Bacteriol. 186:262-265.
9. Higgins, P. G., H. Wisplinghoff, D. Stefanik, and H. Seifert. 2004. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J. Antimicrob. Chemother. 54:821-823.
10. +-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol. Immunol. 47:419-427.
11. +-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol. Lett. 203:235-239.
12. Limansky, A. S., M. A. Mussi, and A. M. Viale. 2002. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J. Clin. Microbiol. 40:4776-4778.
13. Lopez-Otsoa, F., L. Gallego, K. J. Towner, L. Tysall, N. Woodford, and D. M. Livermore. 2002. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J. Clin. Microbiol. 40:4741-4743.
14. Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation- cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380.
15. + antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter. J. Biochem. (Tokyo) 124:187-193.
16. +-driven multidrug efflux pump. J. Bacteriol. 182:6694-6697.
17. Morita, Y., K. Kodama, S. Shiota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42:1778-1782.
18. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.
19. Seward, R. J., T. Lambert, and K. J. Towner. 1998. Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J. Med. Microbiol. 47:455-462.
20. Vila, J., A. Marcos, F. Marco, S. Abdalla, Y. Vergara, R. Reig, R. Gomez-Lus, and T. Jimenez de Anta. 1993. In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 37:138-141.
21. Vila, J., J. Ruiz, P. Goni, and T. Jimenez de Anta. 1997. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J. Antimicrob. Chemother. 39:757-762.
22. Wisplinghoff, H., M. Decker, C. Haefs, O. Knit, G. Plum, and H. Seifert. 2003. Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:177-180.
23. Xu, X. J., X. Z. Su, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzae Rd. Microbiol. Immunol. 47:937-943.
24. VIM-2 gene cassettes. J. Antimicrob. Chemother. 49:837-840.